Johns Hopkins ABX Guide
Nafcillin
INDICATIONS
FDA
FDA
- Treatment of infections caused by methicillin-sensitive Staphylococcus spp.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- MSSA infections
- Endocarditis
- Bacteremia
- Osteomyelitis and septic arthritis
- Pneumonia
- Meningitis and brain abscess
- Skin and soft tissue infections, including diabetic foot, necrotizing fasciitis, and pyomyositis (strep and staph).
- Coagulase staphylococcal infections when susceptible.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 20, 2022
Citation
Auwaerter, Paul G, and Edina Avdic. "Nafcillin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2022. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540376/all/Nafcillin.
Auwaerter PG, Avdic E. Nafcillin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540376/all/Nafcillin. Accessed December 11, 2023.
Auwaerter, P. G., & Avdic, E. (2022). Nafcillin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540376/all/Nafcillin
Auwaerter PG, Avdic E. Nafcillin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. [cited 2023 December 11]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540376/all/Nafcillin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Nafcillin
ID - 540376
A1 - Auwaerter,Paul,M.D.
AU - Avdic,Edina,Pharm.D.
Y1 - 2022/10/20/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540376/all/Nafcillin
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
